Fahey · Scientific reports 2018 · in vitro and phytochemical laboratory study · n=?

The Diversity of Chemoprotective Glucosinolates in Moringaceae (Moringa spp.).

Cited 88 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

In vitro laboratory study and phytochemical analysis with no human participants

PubMed 29789618 · doi:10.1038/s41598-018-26058-4 · record verified 2026-08-30

What was done

Researchers analyzed the glucosinolate (GS) composition in the leaves, seeds, stems, and leaf gland exudates across 12 of the 13 known species in the genus *Moringa*. They tested the chemoprotective capacity of species extracts and 6 purified GS to induce phase 2 cytoprotective responses across multiple cultured cell lines.

What was found

The abstract reports no exact numerical values, concentrations, or fold-induction metrics. Qualitatively, 2 previously unidentified GS were discovered as major components in 6 species, and simple alkyl GS were identified in 4 species (predominating in *M. longituba*). Extracts from 11 of the 12 tested species induced a phase 2 cytoprotective response in cell culture; *M. longituba* exhibited very low activity, while the rare species *M. arborea* showed the highest potency.

Why it matters

This work demonstrates that non-*oleifera* *Moringa* species contain distinct glucosinolates with potent in vitro cytoprotective inducing capacity, highlighting potential botanical candidates for future chemoprotection research.

Limits

The study is entirely in vitro and phytochemical; no animal models or human clinical evaluations were conducted. Quantitative yields, induction concentrations (e.g., CD values), and sample replication counts are omitted from the abstract.

Cited by